Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
AI Influencing Precision Medicine but May Not Match the Hype
May 11, 2018
CLINICAL OMICS
“Facial analysis company FDNA is leveraging AI for facial patterns, essentially automating the task that geneticists have used for years of looking for specific facial traits as clues to the basis of rare genetic diseases. What FDNA does via its facial recognition engine is to effectively broaden the base of available facial images used to reach a diagnosis.”
The article explores the role of artificial intelligence (AI) in advancing precision medicine, with particular attention to FDNA’s contributions. FDNA employs AI decision support tools to enhance the accuracy of personalized healthcare, analyzing complex genomic data to tailor treatments to individual patients. While challenges still exist, FDNA continues to drive progress in utilizing AI for more effective and personalized medical solutions.
Related articles
Continue reading
Interview with Dr. Giulia Pascolini: Unravelling the Genetic Underpinnings of Dermatological Anomalies
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Spanish Coffin Siris Syndrome Association: Fighting for Health and Recognition
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…